140 related articles for article (PubMed ID: 9039219)
21. Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck.
Lippman SM; Spitz MR; Huber MH; Hong WK
Curr Opin Oncol; 1995 May; 7(3):234-41. PubMed ID: 7654825
[TBL] [Abstract][Full Text] [Related]
22. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of oral squamous cell carcinomas.
Scheer M; Kuebler AC; Zöller JE
Onkologie; 2004 Apr; 27(2):187-93. PubMed ID: 15138354
[TBL] [Abstract][Full Text] [Related]
24. Supplemental beta-carotene, smoking, and urinary F2-isoprostane excretion in patients with prior early stage head and neck cancer.
Mayne ST; Walter M; Cartmel B; Goodwin WJ; Blumberg J
Nutr Cancer; 2004; 49(1):1-6. PubMed ID: 15454352
[TBL] [Abstract][Full Text] [Related]
25. Chemoprevention of cancer.
van Zandwijk N; Pastorino U; de Vries N
Eur Respir J; 1993 Mar; 6(3):322-4. PubMed ID: 8472818
[No Abstract] [Full Text] [Related]
26. Positive impact of retinyl palmitate in leukoplakia of the larynx.
Issing WJ; Struck R; Naumann A
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S105-9. PubMed ID: 9065641
[TBL] [Abstract][Full Text] [Related]
27. Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?
Piantadosi S
J Natl Cancer Inst; 1999 Nov; 91(21):1794. PubMed ID: 10547379
[No Abstract] [Full Text] [Related]
28. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?
Narayan K; Crane CH; Kleid S; Hughes PG; Peters LJ
Head Neck; 1999 Oct; 21(7):606-13. PubMed ID: 10487947
[TBL] [Abstract][Full Text] [Related]
29. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.
Lippman SM; Benner SE; Hong WK
Cancer Res; 1994 Apr; 54(7 Suppl):2025s-2028s. PubMed ID: 8137332
[TBL] [Abstract][Full Text] [Related]
30. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Soulières D; Faivre S; Mesía R; Remenár É; Li SH; Karpenko A; Dechaphunkul A; Ochsenreither S; Kiss LA; Lin JC; Nagarkar R; Tamás L; Kim SB; Erfán J; Alyasova A; Kasper S; Barone C; Turri S; Chakravartty A; Chol M; Aimone P; Hirawat S; Licitra L
Lancet Oncol; 2017 Mar; 18(3):323-335. PubMed ID: 28131786
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of a placebo run-in period in a head and neck cancer chemoprevention trial.
Hudmon KS; Chamberlain RM; Frankowski RF
Control Clin Trials; 1997 Jun; 18(3):228-40. PubMed ID: 9204223
[TBL] [Abstract][Full Text] [Related]
32. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
Niles RM
Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
[TBL] [Abstract][Full Text] [Related]
33. Moving toward bioadjuvant approaches to head and neck cancer prevention.
Saba NF; Hammond A; Shin DM; Khuri FR
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S132-5. PubMed ID: 17848282
[TBL] [Abstract][Full Text] [Related]
34. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
Hong WK; Lippman SM; Itri LM; Karp DD; Lee JS; Byers RM; Schantz SP; Kramer AM; Lotan R; Peters LJ
N Engl J Med; 1990 Sep; 323(12):795-801. PubMed ID: 2202902
[TBL] [Abstract][Full Text] [Related]
35. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiology and retinoid chemoprevention of head and neck cancer.
Khuri FR; Lippman SM; Spitz MR; Lotan R; Hong WK
J Natl Cancer Inst; 1997 Feb; 89(3):199-211. PubMed ID: 9017000
[TBL] [Abstract][Full Text] [Related]
37. Chemoprevention strategies in lung carcinogenesis.
Lippman SM; Benner SE; Hong WK
Chest; 1993 Jan; 103(1 Suppl):15S-19S. PubMed ID: 8416769
[TBL] [Abstract][Full Text] [Related]
38. Clinical studies in head and neck cancer chemoprevention.
Gonzalez PM; Benner SE
Cancer Metastasis Rev; 1996 Mar; 15(1):113-8. PubMed ID: 8842482
[TBL] [Abstract][Full Text] [Related]
39. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis.
Rusthoven K; Chen C; Raben D; Kavanagh B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):192-8. PubMed ID: 18078720
[TBL] [Abstract][Full Text] [Related]
40. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
Lippman SM; Lee JJ; Karp DD; Vokes EE; Benner SE; Goodman GE; Khuri FR; Marks R; Winn RJ; Fry W; Graziano SL; Gandara DR; Okawara G; Woodhouse CL; Williams B; Perez C; Kim HW; Lotan R; Roth JA; Hong WK
J Natl Cancer Inst; 2001 Apr; 93(8):605-18. PubMed ID: 11309437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
